Beijing Doing Biomedical Co., Ltd.
5 clinical trials · Sponsor
◉ Watch Beijing Doing Biomedical Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Immunotherapy With CD19 CAR T-cells for B-Cell Lymphoma, ALL and CLL (NCT02546739) | Beijing Doing Biomedical Co., Ltd. | 2021-03-01 |
| Immunotherapy With Bispecific CAR-T Cells for B-Cell Lymphoma, ALL and CLL (NCT03271515) | Beijing Doing Biomedical Co., Ltd. | 2021-03-01 |
| Safety and Efficacy of γδ T Cell Against Gastric Cancer (NCT02585908) | Beijing Doing Biomedical Co., Ltd. | 2019-12-01 |
| Clinical Safety and Preliminary Efficacy of MUC1-DC-CTL Treatment in Stage IV Gastric Cancer. (NCT02602249) | Beijing Doing Biomedical Co., Ltd. | 2017-10-01 |
| Immunotherapy With CD19 CAR γδT-cells for B-Cell Lymphoma, ALL and CLL (NCT02656147) | Beijing Doing Biomedical Co., Ltd. | 2017-10-01 |
Track Beijing Doing Biomedical Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.